Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Tirofiban on Early Neurological Deterioration After Intravenous Thrombolysis in Patients With Acute Ischemic Stroke: an Open-label, Multicenter, Randomized Controlled Trial

NCT06587347 is registered in ClinicalTrials.gov with Capital Medical University as lead sponsor.

NCT NCT06587347
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06587347 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Tirofiban on Early Neurological Deterioration After Intravenous Thrombolysis in Patients With Acute Ischemic Stroke: an Open-label, Multicenter, Randomized Controlled Trial
Lead sponsor
Capital Medical University
Phase
Phase 2/3
Overall status
Not yet recruiting
Start date
November 20, 2024
Completion date
June 30, 2026
Enrollment
302 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute stroke, cerebral infarction, ischemic stroke, acute